SCHEMBL27609587

SCHEMBL27609587

CC(C(=N)NO)S(=O)(=O)Cc1ccc(C(=O)O)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.45
ALDH1A1 P00352 1/20 0.42
TSHR P16473 1/20 0.42
HSD17B10 Q99714 1/20 0.42
MEP1B Q16820 3/20 0.40
HDAC1 Q13547 1/20 0.40
HDAC8 Q9BY41 1/20 0.40
HDAC6 Q9UBN7 1/20 0.40
FOLH1 Q04609 3/20 0.40
CA12 O43570 1/20 0.39
CA1 P00915 1/20 0.39
CA2 P00918 1/20 0.39
CA3 P07451 1/20 0.39
CA4 P22748 1/20 0.39
CA6 P23280 1/20 0.39
CA5A P35218 1/20 0.39
CA7 P43166 1/20 0.39
CA9 Q16790 1/20 0.39
CA13 Q8N1Q1 1/20 0.39
CA14 Q9ULX7 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8997405 0.76 ALDH1A1 (0.52) KMT2AALDH1A1TSHRHSD17B10CA12
SCHEMBL402122 0.70 KMT2A (0.59) KMT2AALDH1A1TSHRHSD17B10CA12
SCHEMBL11581819 0.69 TSHR (0.58) KMT2AALDH1A1TSHRHSD17B10CA12
SCHEMBL1018465 0.69 ALDH1A1 (0.47) KMT2AALDH1A1TSHRHSD17B10CA12
SCHEMBL1018823 0.69 ALDH1A1 (0.61) KMT2AALDH1A1TSHRHSD17B10CA12
SCHEMBL1060743 0.68 TSHR (0.56) KMT2AALDH1A1TSHRHSD17B10CA12
SCHEMBL1060313 0.67 MEP1B (0.49) KMT2AALDH1A1TSHRMEP1BHDAC1
SCHEMBL5435259 0.67 TSHR (0.55) KMT2AALDH1A1TSHRHSD17B10CA12
SCHEMBL12169130 0.67 CA1 (0.59) KMT2AALDH1A1TSHRHSD17B10CA12
SCHEMBL29108711 0.67 TSHR (0.55) KMT2AALDH1A1TSHRHSD17B10CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1578663-A Histone deacetylase inhibitors METHYLGENE INC (CA) 2005-02-09 CN disclosed